Target selection is one of the earliest and most consequential decisions in drug discovery. Today, we’re introducing Kosmos Target Assessment (TA), a specialized version of Kosmos designed to identify therapeutic candidates with the greatest potential to become the next
The AI platform for scientific R&D.
By scientists, for scientists. Spun out from @FutureHouseSF to accelerate research and innovation in science.

